Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ActiveMatrix vs. Standard of Care in Adhesive Capsulitis of the Shoulder
NCT05844930Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Jan 2023
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
A Phase 4 trial of ActiveMatrix in adhesive capsulitis (AC), sponsored by UTHealth Houston. Started Jan 2023; status: completed.
02
Drugs
ActiveMatrix
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT05844930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844930.